AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities

Gajendra, Smeeta; Gupta, Leena; Sahoo, Rani

AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities [Turk J Hematol]

Turk J Hematol. 2026; 43(1): 82-83 | DOI: 10.4274/tjh.galenos.2025.2025.0341

AML with t(8;21): A Molecularly Defined Entity with Morphological Ambiguities

Smeeta Gajendra, Leena Gupta, Rani Sahoo
Laboratory Oncology Unit, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Keywords: Acute myeloid leukemia, t(8, 21)(q22;q22), RUNX1- RUNX1T1 fusion, Atypical chronic myeloid leukemia, Juvenile myelomonocytic leukemia, Cytogenetics, Molecular diagnostics

t(8;21)’li AML: Morfolojik Belirsizlikler İçeren Moleküler Olarak Tanımlanmış Bir Oluşum

Smeeta Gajendra, Leena Gupta, Rani Sahoo
Laboratory Oncology Unit, Dr. B.R.A Institute-Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India

Anahtar Kelimeler: Akut miyeloid lösemi, t(8, 21)(q22;q22), RUNX1-RUNX1T1 füzyonu, Atipik kronik miyeloid lösemi, Jüvenil miyelomonositik lösemi, Sitogenetik, Moleküler tanı

Corresponding Author: Smeeta Gajendra, India
Manuscript Language: English

CITE

Full Text PDF Download citation RIS EndNote BibTex Medlars Procite Reference Manager Send email to author Similar articles PubMed Google Scholar